tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kyle Mikson, 131 are a BUY (83.97%), 25 are a HOLD (16.03%).
Analyst Kyle Mikson, currently employed at CANACCORD, carries an average stock price target met ratio of 37.66% that have a potential upside of 25.45% achieved within 149 days.
Kyle Mikson’s has documented 307 price targets and ratings displayed on 19 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on NTRA, Natera at 13-Oct-2025.
Analyst best performing recommendations are on TTOO (T2 BIOSYSTMS).
The best stock recommendation documented was for TTOO (T2 BIOSYSTMS) at 4/29/2024. The price target of $3 was fulfilled within 1 day with a profit of $0.16 (5.63%) receiving and performance score of 56.34.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$20
$13.27 (197.18%)
$1.5
1 months 11 days ago
(18-Sep-2025)
4/7 (57.14%)
$12.87 (180.50%)
895
Buy
$2
$-4.73 (-70.28%)
5 months 9 days ago
(20-May-2025)
0/1 (0%)
$-5.9 (-74.68%)
Hold
$11
3 years 5 months 18 days ago
(12-May-2022)
1/3 (33.33%)
$4.47 (68.45%)
38
Buy
$31
3 years 6 months 10 days ago
(20-Apr-2022)
3/5 (60%)
$7.27 (30.64%)
31
Which stock is Kyle Mikson is most bullish on?
Which stock is Kyle Mikson is most reserved on?
What Year was the first public recommendation made by Kyle Mikson?
